Mitochondria Archives

Part 2: SLU‑PP‑332: An ERR that Reprograms Muscle Fuel Use

Abstract:

Pan‑ERR activation is a double‑edged sword, however SLU‑PP‑332 avoids some known pitfalls of it’s predecessors. It has been studied in animal models of organ energy metabolism, yet carries possible off‑target effects – especially in the heart – when ERRγ is strongly engaged. Compared with other mimetics (e.g., GW501516; AICAR), SLU‑PP‑332 avoids some known pitfalls; however, it still lacks sufficient human data and testing.

Key Terminology:

Hypertrophy is the growth of muscle cells
Ejection fraction is the % of blood the heart pumps with each beat
Hepatotoxicity is liver damage caused by medications, heavy metals, or other harmful substances

What we know (and don’t) about safety

Cardiac biology is nuanced: ERRγ interacts with the cardiogenic factor GATA4; excessive signaling can drive cardiac hypertrophy – abnormal thickening of the heart muscle. When cardiac hypertrophy occurs, it can impair heart function over time.
Conversely, In pressure‑overload heart failure models, the Pan‑ERR activation compound SLU‑PP‑332 was studied with ejection fraction, fibrosis, and mitochondrial function as measured endpoints (animal data only). SLU‑PP‑332 avoids some known pitfalls of it’s predecessors.
Liver signals in mice: In metabolic‑syndrome studies involving SLU‑PP‑332, investigators reported only minor changes in liver enzymes at the studied doses, and hepatic steatosis was also measured. Human hepatotoxicity risk remains undefined.
Bottom line: Safety may depend on dose, tissue exposure, and physiological context (e.g., healthy vs. heart‑failure physiology). This is why it’s critical to proceed with stage‑gated, human clinical trials for the Pan‑ERR activation SLU‑PP‑332 to avoid known pitfalls of it’s predecessors.

How does SLU‑PP‑332 compare with other exercise mimetics?

Mimetic	Primary target	Key upside	Key concern(s)
SLU‑PP‑332	Pan‑ERR activation	Fat‑oxidation shift, ↑ energy expenditure, ↑ treadmill running time, metabolic readouts measured in obese mice	Potential ERRγ‑linked cardiac hypertrophy risk; human data absent
GW501516 (Cardarine)	PPAR‑δ agonist	Robust treadmill-performance phenotype in animals	Development terminated after rodent carcinogenicity; banned by WADA for athletes
AICAR	AMPK activator	Exercise-mimetic effects in models; improved glucose handling in some models	Effects can be transient; pleiotropic/AMPK‑independent actions; safety profile limits translation

Practical caution:

Unlike over‑the‑counter “supplements,” these agents are research compounds, not approved therapies. GW501516’s history is a cautionary tale: promising performance effects can coexist with unacceptable long‑term risks. However, the Pan‑ERR activation compound SLU‑PP‑332 needs further research to determine if it will have the same fate or if it really is the exercise mimetic of the future.

Works cited

https://www.tga.gov.au/resources/publication/scheduling-decisions-interim/scheduling-delegates-interim-decisions-and-invitation-further-comment-accsacms-november-2017/12-cardarine

https://europepmc.org/article/pmc/pmc3084588

https://pmc.ncbi.nlm.nih.gov/articles/PMC10801787/

https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.123.066542

https://pubmed.ncbi.nlm.nih.gov/24083978/

“For education only; not medical advice; SLU‑PP‑332 is an investigational research compound with no human approval.”

Abstract:

By activating ERRs, SLU‑PP‑332 binds to ERRs that turn on a PGC‑1α–linked gene program. In mouse models, this program is studied for its effects on mitochondrial gene expression and fuel selection.

Step‑by‑step mechanism

Direct receptor activation: SLU‑PP‑332 binds ERRs (non‑selectively across α/β/γ), with multiple lines of evidence showing functional ERRα dependence for the exercise phenotype in mice.
Coactivator recruitment: Activated ERRs recruit PGC‑1α (a transcriptional coactivator of mitochondrial biogenesis genes).
Gene program engagement: SLU‑PP‑332 induces an acute aerobic exercise gene signature in mouse skeletal muscle, including Pdk4. Pdk4 (pyruvate dehydrogenase kinase 4) is an enzyme that inhibits the pyruvate dehydrogenase complex, the gatekeeping enzyme that channels glucose-derived pyruvate into mitochondria.
Cellular remodeling. Mouse studies report changes in oxidative type IIa fiber proportion, mitochondrial content, and expression of respiratory chain components.

Checkpoint

Respiratory exchange ratio (RER): a breath‑level metric; lower RER indicates greater fatty acid use as fuel.
Fatty acid oxidation: the breakdown of fatty acids inside mitochondria.

What the animal studies measured

Fuel selection & energy expenditure: In mice, RER, fatty acid oxidation, and energy expenditure were measured after administration.
Body composition on high‑fat diet: In diet‑induced obese mice, body‑composition endpoints (fat mass and lean mass) were measured over 28 days; see the works cited for the published data.
Glycemic readouts: In high‑fat diet models, glucose tolerance was measured; in chow‑fed mice, fasting/fed glucose and insulin were largely unchanged—highlighting context‑dependent effects.
Treadmill models: In independent work, SLU‑PP‑332 was studied in mouse treadmill models measuring time to exhaustion and running distance.

Research takeaway (early‑stage):

The mechanism overlaps with gene programs engaged by aerobic exercise in mice—but all data so far are preclinical (animal models). No human data exist, and SLU‑PP‑332 is not for human use.